Article
Circular RNA-Encoded MET Variant Is a Targetable Factor in Glioblastoma
2022-06-28
Abstract excerpt
<title>Abstract</title> <p>Activated by its single ligand, hepatocyte growth factor (HGF), the receptor tyrosine kinase MET is pivotal in promoting glioblastoma stem cell (GSC) self-renewal, invasiveness and tumorigenicity. Nevertheless, HGF/MET-targeted therapy has shown limited clinical benefits in glioblastoma patients, suggesting hidden mechanisms of MET signalling in glioblastoma. Here, we show that circular...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8aca7140-eba9-5575-85ed-38bcc8b09713
- DOI
- 10.21203/rs.3.rs-1730428/v1
